Fran Gregory, PharmD, MBA is Vice President of Emerging Therapies for Cardinal Health, responsible for Cell & Gene Therapies and Biosimilars. She has vast experience innovating and leading in healthcare. Beginning in specialty pharmacy, she learned early on the value of complex and life-changing, yet costly, medication management. Leading clinical program development, formulary management, oncology pathways, marketing and product lifecycle management, and value-based care contracting, she has a broad range of expertise. Due
to her years spent in the payer/PBM space, biotech manufacturers as well as her current role at Cardinal Health, she can evaluate opportunities with an expansive perspective. Her passion is helping bring to market the most innovative and life-changing treatments, overcoming challenges in the healthcare system, and leading successful business units and teams.